Clinical Trial Update: A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-050) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating safety and efficacy of adding Anacetrapib to ongoing statin therapy in Japanese participants with heterozygous familial hypercholestero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heterozygous Familial Hypercholesterolemia

Drugs mentioned

• Anacetrapib (anacetrapib)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Heterozygous Familial Hypercholesterolemia (HeFH) | Phase 3 | Status: COMPLETED